Target intelligence / Profile preview

U2 small nuclear RNA auxiliary factor 1-like protein 5 (U2AF1L5)

Target
U2AF1L5
Molecular classification
Other (Predicted member of splicing factor SR protein family; likely related to RNA binding and pre-mRNA splicing per paralog but itself unclassified)
01

Overview

U2 small nuclear RNA auxiliary factor 1-like protein 5 (U2AF1L5) is a predicted protein-coding gene in the human genome that is homologous to the well-characterized U2AF1 gene, which encodes a key splicing factor involved in the recognition of the 3' splice site during pre-mRNA processing[1][5]. U2AF1L5 itself is not functionally characterized, and there is no published evidence supporting its involvement in splicing, disease pathology, or therapeutic targeting. Most information available in published resources refers to its paralog U2AF1, which plays a central role in RNA splicing, implicates in various cancers, and interacts with other splicing factors. Because U2AF1L5 is a *predicted* gene (lacking direct experimental evidence), it should not be referenced as a true protein target for therapeutic or diagnostic purposes unless further research clarifies its function.

Other names
U2AF1L5U2 small nuclear RNA auxiliary factor 1-like protein 5Splicing factor U2AF 35 kDa subunit-like proteinLOC102724594
02

Mechanism of action

None reported

03

Biological functions

Other (No experimentally validated biological function for U2AF1L5; presumed to be involved in RNA splicing by homology with U2AF1[1][5])
04

Disease associations

Other (No known disease associations; U2AF1 mutations are linked to cancer and blood disorders[1][5], but this is not established for U2AF1L5)

Beyond the preview

Go deeper on U2 small nuclear RNA auxiliary factor 1-like protein 5 (U2AF1L5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on U2 small nuclear RNA auxiliary factor 1-like protein 5 (U2AF1L5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call